News Formal

FDA releases guidelines for cannabis-related research, but CBD will have to wait

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 97%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

The U.S. Food and Drug Administration released preliminary guidance on Tuesday on cannabis-related clinical research, outlining how companies seeking approval of drugs that contain cannabis or its derivatives must follow the traditional drug review and approval process involving clinical trials.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA Bans Sale of Puff Bar E-CigarettesThe FDA told the makers of Puff Bar e-cigarettes and other fruity flavored disposable e-cigarettes to take their products off the U.S. market, closing a loophole after the agency cracked down on Juul earlier this year RaulOgaz I still have two of these Oh thank goodness. This...THIS...is what is important right now. Thank you FDA. 🙄 No real problems iguesss.
Source: WSJ - 🏆 98. / 63 Read more »

FDA Calls for Removal of Puff Bar E-Cigarettes From MarketThe agency sent warning letters to nine other companies either selling similarly unauthorized e-cigarettes
Source: TIMEHealth - 🏆 121. / 63 Read more »